by awkolaw2 | May 7, 2018 | Daniel Thornburgh, Defective Medical Devices, Essure, Stephen Echsner
Requires that patients receive risk information before using contraceptive device. In its commitment to ensuring the post-market safety of medical devices, the FDA used their authority to impose a unique restriction on the sale and distribution of the permanent female...
by awkolaw2 | May 6, 2018 | Defective Drugs
FDA was worried Nuplazid was risky but approved its use anyway Nuplazid (pimavanserin) is an anti-psychotic drug manufactured by Acadia Pharmaceuticals that is approved for use in the treatment of debilitating and frightening psychosis in Parkinson’s patients. The...